Anifrolumab, a relatively new monoclonal antigen, is generating considerable excitement within the medical community as a possible option for various immune-related conditions. This innovative medication targets the https://bookmarks-hit.com/story25925059/anifrolumab-a-novel-approach-for-immune-mediated-conditions